Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The intestinal microbiota and improving the efficacy of COVID-19 vaccinations
Jiezhong Chen, Luis Vitetta, Jeremy D. Henson, et al.
Journal of Functional Foods (2021) Vol. 87, pp. 104850-104850
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Animal models for COVID-19: advances, gaps and perspectives
Changfa Fan, Yong Wu, Rui Xiong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 79
Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases
Xiaomin Cheng, Yali Zhang, Yifan Li, et al.
BMC Microbiology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 33
Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy
Virna Margarita Martín Giménez, Javier Modrego, Dulcenombre Gómez‐Garré, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12249-12249
Open Access | Times Cited: 18
Exploring the interaction and impact of probiotic and commensal bacteria on vitamins, minerals and short chain fatty acids metabolism
Luis G. Bermúdez‐Humarán, Benoît Chassaing, Philippe Langella
Microbial Cell Factories (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine
Jingen Zhu, Swati Jain, Jian Sha, et al.
mBio (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 25
Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy
Nesa Kazemifard, Abolfazl Dehkohneh, Shaghayegh Baradaran Ghavami
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 22
Alterations in the gut microbiome and its metabolites are associated with the immune response to mucosal immunization with Lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 spike epitopes in mice
In‐Chan Hwang, Robie Vasquez, Ji Hoon Song, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 8, pp. 1456-1468
Open Access | Times Cited: 12
Untangling the link between the human gut microbiota composition and the severity of the symptoms of the COVID‐19 infection
Leonardo Mancabelli, Christian Milani, Federico Fontana, et al.
Environmental Microbiology (2022) Vol. 24, Iss. 12, pp. 6453-6462
Open Access | Times Cited: 12
Gut microbiome and dietary fibre intake strongly associate with IgG function and maturation following SARS-CoV-2 mRNA vaccination
Genelle Lunken, Liam Golding, Alana Schick, et al.
Gut (2022) Vol. 73, Iss. 1, pp. 1.1-3
Open Access | Times Cited: 12
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV
Shilpa Ray, Aswathy Narayanan, Jan Vesterbacka, et al.
npj Biofilms and Microbiomes (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Ginsenoside Rb1 enhanced immunity and altered the gut microflora in mice immunized by H1N1 influenza vaccine
Chuanqi Wan, Rufeng Lu, Chen Zhu, et al.
PeerJ (2023) Vol. 11, pp. e16226-e16226
Open Access | Times Cited: 5
COVID-19 Vaccination in Kidney Transplant Candidates and Recipients
Claudio Ponticelli, Mariarosaria Campise
Vaccines (2022) Vol. 10, Iss. 11, pp. 1808-1808
Open Access | Times Cited: 9
The Connection between Gut and Lung Microbiota, Mast Cells, Platelets and SARS-CoV-2 in the Elderly Patient
Giovanna Traina
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14898-14898
Open Access | Times Cited: 9
The Gut Microbiome of Children during the COVID-19 Pandemic
Mickayla Bacorn, Hector N. Romero-Soto, Shira Levy, et al.
Microorganisms (2022) Vol. 10, Iss. 12, pp. 2460-2460
Open Access | Times Cited: 9
Dietary Inulin to Improve SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients: The RIVASTIM-Inulin Randomised Controlled Trial
Julian Singer, Matthew Tunbridge, Bree Shi, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 608-608
Open Access | Times Cited: 1
The Concept of Intrauterine Programming and the Development of the Neonatal Microbiome in the Prevention of SARS-CoV-2 Infection
Martina Grot, Karolina Krupa-Kotara, Agata Wypych-Ślusarska, et al.
Nutrients (2022) Vol. 14, Iss. 9, pp. 1702-1702
Open Access | Times Cited: 6
Prolonged Diarrhea Following COVID-19 Vaccination: A Case Report and Literature Review
Tetsuya Akaishi, Takahiro Takahashi, Satoko Sato, et al.
The Tohoku Journal of Experimental Medicine (2022) Vol. 257, Iss. 3, pp. 251-259
Open Access | Times Cited: 5
Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)—rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients
Matthew Tunbridge, Griffith B. Perkins, Julian Singer, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Rapamycin and inulin for third-dose vaccine response stimulation (RIVASTIM): Inulin – study protocol for a pilot, multicentre, randomised, double-blinded, controlled trial of dietary inulin to improve SARS-CoV-2 vaccine response in kidney transplant recipients
Julian Singer, Matthew Tunbridge, Griffith B. Perkins, et al.
BMJ Open (2022) Vol. 12, Iss. 12, pp. e062747-e062747
Open Access | Times Cited: 5
The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical Outcomes
Jiezhong Chen, Luis Vitetta
Frontiers in Bioscience-Scholar (2022) Vol. 14, Iss. 3, pp. 23-23
Open Access | Times Cited: 4
Next-generation probiotic Bacteroides. dorei: Improving the efficacy of COVID-19 vaccinations
Siqin He, Si‐Min Lu, Yuanming Huang, et al.
Journal of Functional Foods (2024) Vol. 116, pp. 106190-106190
Open Access
Microbiota-Based Therapeutics for COVID-19 and Sequelae
Gislane Lelis Vilela de Oliveira
(2024), pp. 691-712
Closed Access
Application and mechanism of natural products and nutrient elements in COVID-19
Lin Zhou, Yulin Tan, Lei Shi, et al.
Journal of Functional Foods (2024) Vol. 123, pp. 106561-106561
Closed Access
Re: “Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial” by Crippa et al.
Luis Vitetta, Tomas Andersen, Michelle Quezada, et al.
Cannabis and Cannabinoid Research (2022) Vol. 7, Iss. 2, pp. 231-233
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top